hr

Hot Keywords
non-alcoholic fatty liver disease epidemiology microenvironment nonalcoholic steatohepatitis transplantation cholangiocarcinoma direct-acting antiviral immunotherapy hepatitis B hepatitis C liver resection imaging cancer stem cell diagnosis gene cirrhosis biomarker recurrence

Top

Chair(s)

  • Allan Tsung

    The Associate Editor of Hepatoma Research. Director of Department of Surgical Oncology, the Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Speakers

  • Timothy M. Pawlik

    Chair of the Department of Surgery in the Ohio State University College of Medicine, the Urban Meyer III and Shelley Meyer Chair for Cancer Research, Columbus, OH, USA.
    Topic: Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor

  • David A. Geller

    Editorial Board member of Hepatoma Research. Richard L. Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, and Director of the UPMC Liver Cancer Center, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
    Topic: Outcomes of laparoscopic liver resection for hepatocellular carcinoma

  • Adam C. Yopp

    Associate Professor in the Department of Surgery and Chief of the Division of Surgical Oncology at UT Southwestern Medical Center, Dallas, Texas, USA.
    Topic: Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises

  • Nicole M. Nevarez

    MD, Department of Surgery, Division of Surgical Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
    Topic: Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises

  • Nuh N. Rahbari

    Vice Chairman and Professor, Department of Surgery, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
    Topic: Minimally-invasive surgical management of hepatocellular carcinoma

  • Georgios Tsoulfas

    MD, PhD, FACS, Professor of Transplantation Surgery, Chief Department of Transplantation Surgery, Aristotle University School of Medicine, Thessaloniki, Greece.
    Topic: The role of technology in the surgical management of hepatocellular carcinoma

  • Emily R. Winslow

    MD, MedStar's Regional Chief of Hepatopancreaticobiliary Surgery, Medstar Georgetown Transplant Institute, Medstar Georgetown University Hospital, Washington, DC, USA.
    Topic: HCC: Insights from the development of LIRADs

  • Zachary J. Brown

    Clinical instructor in surgical oncology, Division of Surgical Oncology, Department of Surgery, the Ohio State University Wexner Medical Center, Columbus, OH, USA.
    Topic: Adjuvant treatment of hepatocellular carcinoma after resection

  • Joal Beane

    Surgical oncologist, Department of Surgery, the Ohio State University Wexner Medical Center and James Comprehensive Cancer Center and Solove Research Institute, Columbus, OH, USA.
    Topic: Optimal hepatic surgery

Programme

      Time (USA, GMT-5)
      Speakers
      Topics
      8:00 - 8:05 AM
      Allan Tsung
      Welcome Speech
      8:05 - 8:25 AM
      Zachary J. Brown
      Adjuvant treatment of hepatocellular carcinoma after resection
      8:25 - 8:45 AM
      Timothy M. Pawlik
      Hepatocellular carcinoma beyond Barcelona clinic liver cancer resection criteria: resecting the aggressive tumor
      8:45 - 9:10 AM
      Adam C. Yopp & Nicole M. Nevarez
      Anatomic vs. non-anatomic liver resection for hepatocellular carcinoma: standard of care or unfilled promises?
      9:10 - 9:30 AM
      David A. Geller
      Outcomes of Laparoscopic Liver Resection for hepatocellular carcinoma
      9:30 - 9:45 AM
      Allan Tsung
      Discussion with the Speakers (Q&A)
      9: 45 - 10:05 AM
      Georgios Tsoulfas
      The role of technology in the surgical management of hepatocellular carcinoma
      10:05 - 10:25 AM
      Nuh N. Rahbari
      Minimally-invasive surgical management of hepatocellular carcinoma
      10:25 - 10:45 AM
      Joal Beane
      Optimal Hepatic Surgery
      10:45 - 11:05 AM
      Emily R. Winslow
      HCC: Insights from the development of LIRADs
      11:05 - 11:20 AM
      Allan Tsung
      Discussion with the Speakers (Q&A)
© 2016-2021 OAE Publishing Inc., except certain content provided by third parties